NuCana (NCNA) Shares Outstanding (Weighted Average) (2016 - 2025)

NuCana's (NCNA) quarterly Shares Outstanding (Weighted Average) came in at $14.9 billion in Q4 2025, up 204791.13% year-on-year from N/an in Q4 2024, and up 204791.13% quarter-over-quarter from $7.3 million in Q4 2024.

NuCana (NCNA) Shares Outstanding (Weighted Average) (2016 - 2025) Analysis & Trends

NuCana has disclosed Shares Outstanding (Weighted Average) across 10 years of filings, most recently posting $14.9 billion for Q4 2025.

  • Shares Outstanding (Weighted Average) for Q4 2025 came in at $14.9 billion, up 204791.13% year-over-year; the trailing twelve-month figure through Dec 2025 was $14.9 billion (up 204791.13% YoY), and the FY2025 annual result was $14.8 billion, up 203826.12% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $14.9 billion for Q4 2025 at NuCana, up from $7.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $14.9 billion in Q4 2025 to a low of $261994.9 in Q1 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $1.6 million (2021), against an average of $1.5 billion.
  • Across the five-year window, Shares Outstanding (Weighted Average) plunged 39.94% in 2022 and surged 204791.13% in 2025, its largest moves.
  • NuCana's Shares Outstanding (Weighted Average) stood at $2.8 million in 2021, then slipped by 12.65% to $2.5 million in 2022, then climbed by 6.78% to $2.6 million in 2023, then soared by 177.9% to $7.3 million in 2024, then soared by 204791.13% to $14.9 billion in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $14.9 billion (Q4 2025), $7.3 million (Q4 2024), and $2.6 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 185,491.37 Bn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 400.00 Bn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 4,489.46 Bn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 118.76 Bn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 417.01 Bn
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 254.10 Mn
9 Abivax 94.26 Bn 94.26 Bn - 928.40 Mn
10 NuCana 29.13 Bn 29.13 Bn - 14.94 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 14.94 Bn
Dec 31, 2024 7.29 Mn
Dec 31, 2023 2.62 Mn
Jun 30, 2023 312,840.79
Dec 31, 2022 2.46 Mn
Jun 30, 2022 302,235.41
Dec 31, 2021 2.81 Mn
Sep 30, 2021 716,863.34
Jun 30, 2021 503,182.17
Mar 31, 2021 261,994.95
Dec 31, 2020 2.70 Mn
Sep 30, 2020 709,776.52
Jun 30, 2020 384,925.64
Mar 31, 2020 153,823.80
Dec 31, 2019 1.67 Mn
Sep 30, 2019 517,966.50
Jun 30, 2019 385,893.79
Mar 31, 2019 221,318.44
Dec 31, 2018 1.66 Mn
Sep 30, 2018 417,104.94